Olympus Corporation (7733.T)
- Previous Close
2,210.50 - Open
2,166.00 - Bid --
- Ask --
- Day's Range
2,083.00 - 2,177.00 - 52 Week Range
1,782.00 - 2,482.50 - Volume
10,478,800 - Avg. Volume
4,286,639 - Market Cap (intraday)
2.577T - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
69.93 - EPS (TTM)
29.98 - Earnings Date May 10, 2024
- Forward Dividend & Yield 36.00 (1.63%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
2,428.30
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.
www.olympus-global.comRecent News: 7733.T
Performance Overview: 7733.T
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7733.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7733.T
Valuation Measures
Market Cap
2.58T
Enterprise Value
2.50T
Trailing P/E
70.04
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.98
Price/Book (mrq)
3.44
Enterprise Value/Revenue
2.73
Enterprise Value/EBITDA
16.76
Financial Highlights
Profitability and Income Statement
Profit Margin
29.52%
Return on Assets (ttm)
3.03%
Return on Equity (ttm)
5.88%
Revenue (ttm)
916.09B
Net Income Avi to Common (ttm)
39.47B
Diluted EPS (ttm)
29.98
Balance Sheet and Cash Flow
Total Cash (mrq)
377.36B
Total Debt/Equity (mrq)
40.63%
Levered Free Cash Flow (ttm)
184.03B